Protection against the harmful effects of chemicals on the development of the nervous and immune system, through better use of already planned animal studies The information from Appendices I, II and IV regarding relevant data obtained through the conducted open literature search, all assessed chemicals and identified metabolites of the assessed substances using the OECD Toolbox program respectively, was not made available at the time this report was published due to confidentiality issues.
Foreword
This project was conducted with funding from the Nordic Council of Ministers. The work was performed by the project consultant, Giorgiana-Adina Tenie (M.Sc. Toxicology; B.Pharm), and guided by the steering group (Table 1) . The information gathered in this project is being further assessed by the Danish Environmental Protection Agency in collaboration with Competent Authorities from other Member States. When adequate and relevant, the obtained information has already been for some substances and will be used in the future cases to propose inclusion of examination of effects on the developing immune system and/or developing nervous system in the Extended One Generation Reproductive Toxicity Studies (EOGRTS) proposed to be performed as part of the REACH standard information requirements. Some of the proposals have already been brought forward and discussed at the Member State Committee in ECHA.
This work is relevant for authorities in the EU (member states, ECHA and the EU Commission), and for authorities from other countries across the world, which can make use of the results. From a broader perspective, the target group of this project is consumers, professional and industrial workers, since the work aims to improve protection from adverse effects on the developing nervous and immune system. 
Background
Effects of chemicals on the developing brain and immune system are of high concern in the Nordic countries and the EU. Such effects can be caused by substances acting through many different modes of action, including endocrine disrupting substances (for example bisphenol A affects the developing brain and the immune system, and perflourinated substances also interfere with the immune system).
Information on developmental neurotoxicity (DNT) and developmental immunotoxicity (DIT)
is not available for most of the substances used for instance in consumer products today, but under current EU regulation (REACH) there is an unique possibility to get information on these effects for some of the substances used in high tonnages. The testing for DNT and DIT is concern driven and it is therefore crucial to identify all relevant data to trigger these investigations.
Under REACH, the requirements in regards to testing for reproductive toxicity depends on the production (or import) tonnage level of the substance. For the highest tonnage levels, an Extended One Generation Reproductive Toxicity Study (EOGRTS) (OECD TG 443) has recently substituted the "two generation reproductive toxicity study" (OECD TG 416) as a standard information requirement.
The EOGRTS was implemented in REACH in 2015. The European Chemicals Agency (ECHA) can therefore now in the evaluation processes (including dossier evaluation: compliance check and testing proposals, and substance evaluation, see section 1.1) request EOGRTS. In each case, the design of the study must be specified. The EOGRTS in REACH is composed of a basic design, which can be supplemented with investigation of the following areas (cohorts): Second generation (F2), effects on the development of the brain (DNT) and effects on the immune system during development (DIT) -if data are available, which trigger these cohorts (see section 1.2). Such conditional testing makes the availability of relevant triggering data crucial for justifying the mentioned investigations.
In the dossier evaluation process, if an EOGRTS is considered, ECHA searches for data relevant for triggering of the cohorts in the registration dossier and in a limited number of publicly available databases. ECHA's search strategy includes identification of analogues used by the Registrants or assessed by international evaluation bodies, but does not include search in the open literature [ECHA, 2016a] . Searching for triggers in the public literature is therefore either left out or a possibility for the Member State Competent Authorities MSCAs to perform.
From 2016, some MSCAs e.g. from Denmark and Sweden, assisted ECHA in a search for triggers outside the registration dossiers. This included a project (for a master degree) in which information in the open literature for potential triggers for 40 substances was searched and data for about 20% of substances found. It was at that time acknowledged that the resources in the national agencies are very limited, and it would not be possible to carry out a search for around 400 pending cases. This Nordic project was therefore initiated to promote inclusion of the relevant cohorts when the EOGRTS was requested.
Evaluation process in REACH
The Evaluation process under REACH (Figure 1 ) consists of Dossier Evaluation (DEV) and Substance Evaluation [ECHA, 2017] (SEV). Dossier Evaluation (DEV) aims to improve quality of the registration dossiers and it includes two processes: Testing Proposal Examinations (TPE) and Compliance Checks (CCH), while SEV aims to clarify identified concern(s) [ECHA, 2017] . 
Purpose and objective of the project
In this project, the Nordic Countries have assisted ECHA in searching for information relevant for triggering of DNT, DIT outside the registration dossiers. The aims were to promote design of EOGRTS with specific investigations DNT, DIT and F2 when justified by the evidence found. The overall aim of the project was to increase the level of protection of the population from effects on the developing brain and the developing immune system. Information on endocrine effects or mode of action has been considered as a trigger for all three cohorts DNT, DIT and F2. The project also aimed to support a better utilization of animal studies, since when cohorts are investigated, more information is obtained from the animals already used in the studies.
The project objective was to search the open scientific literature for EOGRTS triggers for approximately 100 substances. Secondly, for a limited number of cases, an analysis of the outcome from the regulatory decision process in respect to the design of the EOGRTS was included in the project.
Methodology

Data search
Search strategy
The search strategy used in this project was developed based on the text regarding inclusion of the cohorts in the EOGRTS from the standard data requirement for EORGTS according to REACH Annexes IX and X, Section 8.7.3. (see section 1.2), as well as the ECHA endpoint specific guidance chapter R.7.6 of ECHA, TGD R.7a [ECHA, 2015] . The search strategy was subject to refinement during the project. Therefore, some searches were performed for all substances, whereas others were only performed for the last app. 50 substances, as outlined below:
A) Search in the open scientific literature using PubMed (all substances) and also PubChem, HSDB, NTP and Haz-Map (for app. 50 substances).
B) Search in publicly available databases on suspected endocrine disruptors (all substances).
C) Search for (Q)SAR predictions (all substances).
D) Search for the above (A, B, C) for constituents in cases where registered substances were multiconstituent substances or UVCBs. E) Search for the above (A, B, C) for analogues identified by ECHA (all substances).
F) Search for possible triggering information in the repeated dose toxicity and reproductive toxicity studies in the registration dossier (for app. 50 substances).
G) Search for metabolites (for app. 50 substances)
Ad A)
The scientific literature search (screening) for all substances was performed using PubMed as a primary database. To identify potential triggers for extending the EOGRTS design to include the F2, DNT and/or DIT cohorts, specific filters in association with the name of the assessed substance (parent chemical) were employed (Table 2 ). In addition, synonyms and trade names of the assessed substances according to the registration dossier, were used in combination with the search filters. The screening process was refined during the project through extending the number of the used databases. In order to allow a more extensive search of the publicly available scientific literature for potential triggers for the F2, DNT and/or DIT cohorts, in addition to screening only PubMed (for the first investigated 50 substances), 4 more databases were used (for the last app. 50 substances): Three different publicly available online sources were used for investigating the ED potential (ED-screening) of the assessed substances:
 TEDX list of endocrine disruptors, available at http://endocrinedisruption.org/  SIN list, available at http://chemsec.org  EU Commission database of suspected endocrine disruptors, available at http://ec.europa.eu/environment/chemicals/endocrine/strategy/substancesen.html Ad C) (Q)SAR predictions of endocrine disruptive properties were obtained from the Danish (Q)SAR database, and only the positive predictions were used as possible triggering elements for further assessment:
The analogues of each parent chemical identified by ECHA in their search was noted, and the open literature, databases on suspected endocrine disruptors and (Q)SAR predictions were further screened for information on each analogue (as described above, in Ad A, B and C). Ad E)
Search filters
Some of the assessed chemical substances were substances of unknown or variable composition, complex reaction products or biological materials, collectively called UVCBs under the REACH legislation. In these cases, the constituents of each UVCB were identified from the registration dossier and the searches described above (in A, B, C) were performed for each of the found constituents.
Ad F)
Another refinement in the search methodology introduced during the project, was the inclusion of the existing reproductive toxicological information (from the registration dossier) for each parent chemical, in the Microsoft Excel document used to collect the results. This contributed to directing the search of the open literature towards other unknown / not reported DNT and / or DIT-related effects. Therefore, the screening process became less time-consuming through not focusing on the references related to already known and reported DNT and/or DIT triggers.
Ad G)
The OECD QSAR Toolbox program was employed for identifying the metabolites of the parent chemicals. Two different types of metabolites, documented (observed) and simulated, were retrieved for each assessed substance (Appendix III).
Since it was the case that one parent chemical had several metabolites, the results of this step were compiled in a different Microsoft Excel document than the Microsoft Excel one with the results of the project (Appendix IV). Due to a limited timeframe for conducting this Nordic project, it was not possible to perform the literature search process for the retrieved metabolites.
Assessed substances
The substances included in the project consisted of: 121 "parent" substances, 46 constituents of the parent substances and 82 analogues (Appendix II).
A total of 385 metabolites were identified (using the OECD QSAR Toolbox program) for 35 of the 121 parent chemicals (Appendix IV) but the literature screening was not conducted for the metabolites, due to time restraints.
Collection of information on substances
The scientific articles retrieved from PubMed and other databases were further saved in pdf format and assessed for potential to trigger the F2, DNT and/or DIT cohorts.
All obtained information was recorded in Microsoft Excel documents. This information was forwarded to the members of the steering group (see Table 1 ). For substances for which all available information (gathered in this project or otherwise present in the registration dossiers and/or provided by ECHA) raised a concern for DNT and/or DIT, and the cohorts were not already included in the draft decision proposed by ECHA, the MSCAs submitted proposals to include the relevant cohorts. The decision making for such cases was referred to MSC.
During the timeline of this project, the outcome of five MSC meetings (MSC 47 -MSC 51) for 19 substances was evaluated using the publicly available "Minutes" from those meetings, where the summary records of MSC discussions and voting are included. Detailed information on the content of PfAs, the responses from ECHA and MSC discussions are not publicly available. 14 substances with EOGRTS included in the agenda of MSC 52 are listed but the outcome not analysed because the Minutes from this meeting were not available at the time this report was drafted.
Results
Relevant data obtained in the conducted search
Data obtained through the literature search
The literature screening process retrieved possible relevant references for 84 out of 249 assessed substances (parent chemicals, analogues, constituents), for 48 out of 121 parent chemicals, for 26 out of 82 investigated analogues and for 10 out of 46 constituents (Figure 2 ). The retrieved relevant references were linked to DNT for 28 cases, DIT in 29 and 14 ED MoA (Figure 3 ), the latter with data relevant for potential triggering of all three cohorts DNT, DIT and F2. 
Data obtained from ED databases on suspected ED MoA
Three databases (TEDX, SIN list and EU COM) were used in order to assess the potential endocrine disrupting properties of the investigated substances (Table 3) . DNT not requested [ECHA, 2016e] 4.2.4. Other effects DIT not requested [ECHA, 2016c] 4.2.5. Results from MSC 52 Table 9 . List of the DEV cases discussed at the MSC meetings, with changes in the decision adopted by ECHA (cases for which the extension of the EOGRTS design was requested, based on the submitted PfAs). DNT requested [ECHA, 2016c] 
Cases with a change in the decision
MSC
Discussion and conclusion
This project contributes to the implementation of REACH regulatory requirements for the EOGRTS, at an early stage, when there is little experience in interpretation of data for triggering of the F2, DNT and/or DIT cohorts.
Information gathered from the open scientific literature may, for some substances, indicate potential effects on the developmental neuro-and immune systems, and be used to trigger the test design allowing such specific investigations under REACH. Our analysis showed that the open scientific literature search resulted in retrieving of potentially relevant information for triggering of the F2, DNT and/or DIT cohorts for 48 out of 121 assessed parent chemicals (39 % of analysed cases). Most of the findings were related to the parent substances, a significant number was also retrieved by searching analogues (26/82) and constituents (10/46) for the multi-constituent or UVCB substances. The retrieved potentially relevant information was linked to DNT (28 substances), DIT (29 substances) and ED MoA (14 substances), the endocrine disrupting data potentially being used for triggering of all three EOGRTS cohorts. These results indicate that there has been some interest of the scientific community to investigate effects of substances produced or imported at high tonnage in the EU. However, the awareness about scientific questions that are of regulatory interest and substances that are under regulatory scrutiny could be increased by improved communication between regulatory authorities and scientists in the relevant fields. ECHA is continuously improving the regulatory transparency via its dissemination website and could further consider those elements.
Until the date of the drafting of this report (February 2017) , 33 substances have been discussed from an EOGRTS perspective at the 47-52 MSC meetings. This early experience from the MSC discussions on the design of EOGRTS shows the lack of immediate success in using the scientific publications from the open literature in triggering of specific investigations for DNT, DIT or F2 in EOGRTS. For those still very few discussed and analysed cases (19 substances), PfAs submitted for one substance led to triggering of both DNT and F2. The systematic evaluation of the reasons for the lack of acceptance by ECHA and several member states for the PfAs and the triggers therein was not in the scope of this project (and may be difficult due to the limited reporting).
The MSC discussions identified several general scientific questions that could be addressed by the scientific community and/or regulatory authorities. Those include e.g.:
1. Are narcotic effects in the acute or repeated dose studies with adult animals a basis for concern for developmental neurotoxicity of the substance, and what are the most sensitive DNT endpoints? Observed rat in vivo "Documented metabolic pathways, extracted from scientific literature and associated with in vivo biotransformation of xenobiotic chemicals in rodents."
Observed rat liver S9 "Documented metabolic pathways for chemicals observed with the use of in vitro experimental systems such as rodent (mostly rat) liver microsomes and S9 fraction."
SIMULATED Type of simulator
The OECD QSAR Toolbox uses a database that contains information about:
Autooxidation, Autooxidation (alkaline medium) "Autoxidation (AU) is a spontaneous, air-induced oxidation of organic molecules. It is a free-radical chain reaction of a chemical with molecular oxygen, resulting in the formation of oxidation products. Among the latter, organic hydroperoxides are regarded as the most important with respect to eliciting adverse effects such as contact allergy. An AU model was therefore developed to simulate the observed AU pathways. The AU simulator consists of a set of molecular transformations, extracted from the observed AU pathways." Dissociation "Dissociation simulation module."
Hydrolysis (acidic medium), Hydrolysis (basic medium)
"Hydrolysis simulator (acidic / basic) predicts hydrolysis products of discrete organic chemicals under the following experimental conditions: acidic pH, ambient or room temperature and atmospheric pressure. The simulator was developed based on data collected from various sources, including articles and public web sites."
Hydrolysis (neutral medium)
"Hydrolysis simulator is an abiotic model and predicts the hydrolysis products of chemicals and their quantities at 28 day under neutral or nearly neutral pH. The model predicts hydrolysis products of discrete organic chemicals under the following experimental conditions: neutral or nearly neutral pH, ambient or room temperature and atmospheric pressure. The simulator was developed based on data collected from various sources, including articles and public web sites."
In vivo rat metabolism
"The current in vivo rat liver metabolic simulator (transformation table) represents electronically designed set of 609 structurally generalized, hierarchically arranged abiotic and enzymatic transformation reactions, which are characteristic for the metabolism for in vivo experimental systems such as rodent (mostly rat). The principal applicability of this simulator is associated with the reproduction as well as the prediction of the metabolic activation reactions and pathways of xenobiotic chemicals, which may elicit in vitro genotoxicity effects such as bacterial mutagenicity and chromosomal aberrations. Each transformation in simulator consists of source and product structural fragments, and inhibiting "masks". A probability of occurrence is ascribed to each principal transformation, which determines its hierarchy in the transformation list. A training set of xenobiotic chemicals of a wide structural diversity, with experimentally observed metabolic reactions and pathways has been built, using published data on their liver metabolism. The data on their metabolism are collected mostly from research publications in the field from selected scientific journals, monographs and websites, and are associated with the commonly observed in vivo liver metabolic reactions of chemicals with different structures."
Microbial metabolism "Multiple pathway catabolism is simulated using the abiotic and enzyme-mediated reactions via the hierarchically ordered principal molecular transformations extracted from documented metabolic pathway database. The hierarchy of the transformations is used to control the propagation of the catabolic maps of the chemicals. The simulation starts with the search for match between the parent molecule and the source fragment associated with the transformation having the highest hierarchy. If the match is not found search is performed with the next transformation, etc. When the match is identified, the transformation products are generated. The procedure is repeated for the newly-formed products. Predictability (probability that the metabolite is observed, given that the metabolite is predicted) evaluated on the bases of documented catabolism for 200 chemicals stored in the database of <<Observed microbial catabolism>> is 83%."
Rat liver S9 metabolism
"The current in vitro rat liver metabolic simulator (transformation table) represents electronically designed set of 509 structurally generalized, hierarchically arranged biotransformation reactions, which are characteristic for the metabolism for in vitro experimental systems such as rodent (mostly rat) liver microsomes and S9 fraction. The principal applicability of this simulator is associated with the reproduction as well as the prediction of the metabolic activation reactions and pathways of xenobiotic chemicals, which may elicit in vitro genotoxicity effects such as bacterial mutagenicity and chromosomal aberrations. A training set of xenobiotic chemicals of a wide structural diversity, with experimentally observed metabolic reactions and pathways has been built, using published data on their metabolism in rodent liver microsomes and S9 fraction."
Skin metabolism
"Skin metabolism simulator mimics the metabolism of chemicals in the skin compartment. Given the lack of reported skin metabolism data and the widespread hypotheses is that skin enzymes can metabolize absorbed xenobiotics via reactions analogous to those determined in liver, the simulator was developed as a simplified mammalian liver metabolism simulator. The skin metabolism simulator contains a list of hierarchically ordered principal transformations, which can be divided into two main types -rate-determining and non-rate-determining. The rate-determining transformations are Phase I and Phase II, such as C-hydroxylation, ester hydrolysis, oxidation, glutathione conjugation, glucuronidation, sulfonation. The non-ratedetermining transformations include molecular transformations of highly reactive intermediates. The simulator starts by matching the parent molecule with the reaction fragments associated with the transformation having the highest probability of occurrence. This produces a set of first level metabolites. Each of these derived metabolites is then submitted to the same list of hierarchically ordered transformations, to produce a second level of metabolites. "
